Nexo Therapeutics

Littleton, United States

Nexo Therapeutics offers treatments for some of cancer's most intractable targets.

$60.0M raised

Jul 2023

Series A

Biotechnology Life Science Therapeutics

Top Investors

New Enterprise AssociatesCormorant Asset ManagementVersant Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nexo Therapeutics

How much funding has Nexo Therapeutics raised?

Nexo Therapeutics has raised $60.0M in total funding. The most recent round was Series A. The last funding was announced in July 2023.

Who are Nexo Therapeutics's investors?

Nexo Therapeutics's investors include New Enterprise Associates, Cormorant Asset Management, Versant Ventures.

Where is Nexo Therapeutics headquartered?

Nexo Therapeutics is headquartered in Littleton, United States.

What does Nexo Therapeutics do?

Nexo Therapeutics offers treatments for some of cancer's most intractable targets.

What stage is Nexo Therapeutics at?

Nexo Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 26, 2023.

MLA

"Nexo Therapeutics — Funding & Investors." VCBacked, July 26, 2023, https://www.vcbacked.co/company/nexo-therapeutics. Accessed June 4, 2026.

APA

VCBacked. (2023). Nexo Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/nexo-therapeutics

Wikipedia (cite web)

{{cite web |title=Nexo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nexo-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 26, 2023.

Similar Companies in Biotechnology